The Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation is supported by six corporate sponsors; Amylin Pharmaceuticals, Ferring Research Institute, Ipsen, the PolyPeptide Group, Roche and Zydus Cadilla. To read more about our corporate sponsors and board members, click here.

The Foundation’s current programs include sponsoring the Annual Peptide Therapeutics Symposium now in its sixth year and the commission and commercialization of the Peptide Therapeutics Database and a report on Development Trends for Peptide Therapeutics.

The Annual Peptide Therapeutics Symposium held every year in San Diego California is a unique forum which brings together world leaders from academia, the biopharmaceutical industry, CMOs, CROs, and investors interested in all aspects of peptide R&D, including drug discovery, safety and toxicology, clinical development, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. To review the program for this year and register please click here.

The Peptide Therapeutics database and the report on Development Trends for Peptide Therapeutics are sponsored through a grant from the Peptide Therapeutics Foundation underwritten by our corporate partners. To download a sample of these products or to purchase on-line please click here.